Business Description
SynBiotic SE
ISIN : DE000A3E5A59
Share Class Description:
XTER:SBX: Registered SharesCompare
Compare
Traded in other countries / regions
SBX.Germany IPO Date
2021-01-06Description
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.76 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | -0.49 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.98 | |||||
| Beneish M-Score | -1.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -38.2 | |||||
| 3-Year EBITDA Growth Rate | -49.2 | |||||
| 3-Year EPS without NRI Growth Rate | -60.7 | |||||
| 3-Year FCF Growth Rate | 33.9 | |||||
| 3-Year Book Growth Rate | -30.8 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 96.46 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.99 | |||||
| 9-Day RSI | 41.11 | |||||
| 14-Day RSI | 43.69 | |||||
| 6-1 Month Momentum % | -49.36 | |||||
| 12-1 Month Momentum % | 26.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.81 | |||||
| Quick Ratio | 0.47 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 242.84 | |||||
| Days Sales Outstanding | 17.59 | |||||
| Days Payable | 172.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23.2 | |||||
| Shareholder Yield % | 2.33 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.74 | |||||
| Operating Margin % | -311.12 | |||||
| Net Margin % | -298.35 | |||||
| FCF Margin % | -36.04 | |||||
| ROE % | -126.95 | |||||
| ROA % | -64.5 | |||||
| ROIC % | -72.24 | |||||
| 3-Year ROIIC % | 575.03 | |||||
| ROC (Joel Greenblatt) % | -496.19 | |||||
| ROCE % | -84.16 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 306 | |||||
| PS Ratio | 3.32 | |||||
| PB Ratio | 1.88 | |||||
| EV-to-EBIT | -1.31 | |||||
| EV-to-Forward-EBIT | 85.08 | |||||
| EV-to-EBITDA | -4.55 | |||||
| EV-to-Forward-EBITDA | 22.69 | |||||
| EV-to-Revenue | 4.17 | |||||
| EV-to-Forward-Revenue | 1.48 | |||||
| EV-to-FCF | -11.56 | |||||
| Earnings Yield (Greenblatt) % | -76.34 | |||||
| FCF Yield % | -8.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SynBiotic SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 8.166 | ||
| EPS (TTM) (€) | -5.371 | ||
| Beta | 0.81 | ||
| Volatility % | 156.98 | ||
| 14-Day RSI | 43.69 | ||
| 14-Day ATR (€) | 0.289074 | ||
| 20-Day SMA (€) | 6.075 | ||
| 12-1 Month Momentum % | 26.61 | ||
| 52-Week Range (€) | 2.86 - 19.5 | ||
| Shares Outstanding (Mil) | 5.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SynBiotic SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SynBiotic SE Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
SynBiotic SE Frequently Asked Questions
What is SynBiotic SE(XTER:SBX)'s stock price today?
The current price of XTER:SBX is €5.92. The 52 week high of XTER:SBX is €19.50 and 52 week low is €2.86.
When is next earnings date of SynBiotic SE(XTER:SBX)?
The next earnings date of SynBiotic SE(XTER:SBX) is .
Does SynBiotic SE(XTER:SBX) pay dividends? If so, how much?
SynBiotic SE(XTER:SBX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers